Clik here to view.
Aphios, VivaCell to Develop Cannabinoid-Based Drugs for MS, CNS Disorders
Aphios, VivaCell to Develop Cannabinoid-Based Drugs for MS, CNS Disorders Genetic Engineering News Aphios and VivaCell have executed research and commercialization agreements to develop these drug...
View ArticleClik here to view.
Tumor Immunotherapy Efficacy Increased In Both Breast And Prostate Cancer...
Tumor Immunotherapy Efficacy Increased In Both Breast And Prostate Cancer … Daily Markets NORCROSS, Ga., June 12, 2013 /PRNewswire-USNewswire/ — Galectin Therapeutics (GALT), the leading developer of...
View ArticleClik here to view.
DRUG SCALEUP AND MANUFACTURING INTERNATIONAL BY DR ANTHONY M CRASTO, WORLD...
http://drug-scaleup-and-manufacturing.webnode.com/news/my-website-on-scaleup-of-organic-compounds/
View ArticleClik here to view.
Clik here to view.
Does This Pipeline Promise Tomorrow’s Blockbuster Sales?
Does This Pipeline Promise Tomorrow’s Blockbuster Sales? DailyFinance The company currently has six drugs and indications under review for regulatory approval, with 15 more therapies undergoing phase 3...
View ArticleClik here to view.
Portable TB Detector
A device for the genetic detection of pathogenic bacteria has emerged from microfluidics research coupled with NMR spectroscopy Read more
View ArticleClik here to view.
Targeting Cholera Toxin
The synthesis and initial biological evaluation of a calixarene-based inhibitor for cholera toxin has been developed Read more
View ArticleClik here to view.
Nanoparticle-based Anti-influenza Vaccine
Hemagglutinin-based nanoparticles are a novel generation of vaccines against influenza Read more
View ArticleClik here to view.
Targeting an Undruggable Protein
Deltarasin is a novel anti-tumoral drug which targets KRAS by inhibiting its association with PDEd Read more
View ArticleClik here to view.
The art of antibody process development –Drug Discovery Today
Figure 1. Schematic of an antibody. Pfizer’s developmental compound tremelimumab is an antibody of subclass IgG2 and is composed of four proteins linked by disulfide bonds. Many antibodies are...
View ArticleClik here to view.
Elucidating Heterocyclic Chemistry in Pharmaceuticals
Researchers at the Scripps Research Institute advance heteorcylic chemistry trhough new reagents and reaction-tracking techniques....
View ArticleClik here to view.
ThromboGenics’ Jetrea receives NICE approval for eye condition treatment
http://drugdelivery.pharmaceutical-business-review.com/news/thrombogenics-jetrea-receives-nice-approval-for-eye-condition-treatment-130613 ThromboGenics’ Jetrea receives NICE approval for eye...
View ArticleClik here to view.
Double strike against cancer
13.06.2013 – German researchers have found a way to circumvent chemotherapy resistance in cancer cells. A new therapeutic approach can take advantage of cancer cells’ need to repair double-strand...
View ArticleClik here to view.
London University discovers vital clue to how cancer spreads
Researchers at University College London have made a key discovery about how cancer spreads through the body, which could lead to drugs being developed to halt the process. Scientists at the...
View ArticleClik here to view.
MEDICINE IN ANCIENT GREECE
Homer Medicine In Homer The earliest source of Greek medical knowledge and descriptions of ancient Greek medical practices is Homer. The two epic poems attributed to Homer, the Iliad and the...
View ArticleClik here to view.
Amgen In Focus
Amgen In Focus Seeking Alpha According to Amgen, they have 45 drugs in development from Phase 1 to Phase 3. Conversely, Gilead has 32 drugs in development and Pfizer has 64. Meanwhile, Gilead only has...
View ArticleClik here to view.
Japanese MHLW clears Roche’s Avastin as glioblastoma therapy
Japanese MHLW clears Roche’s Avastin as glioblastoma therapy The Japanese Ministry of Health, Labour and Welfare (MHLW) has cleared Roche’s Avastin (bevacizumab) as a combination therapy and...
View ArticleClik here to view.
EMA clears Roche’s polyarticular juvenile idiopathic arthritis drug
EMA clears Roche’s polyarticular juvenile idiopathic arthritis drug The European Medicines Agency has cleared Roche’s RoACTEMRA for the treatment of a rare form of arthritis, polyarticular juvenile...
View ArticleClik here to view.
HOW ICH IS CHANGING DRUG DEVELOPMENT,REG STARTING MATERIALS AND BIG IDEAS
The desire for a dramatic increase in process understanding over the past eight years has left industry leaders and Global Health Agencies searching for a more relevant model for developing process...
View ArticleClik here to view.
Supervision of Chinese-Made Drug Substances by Philippe André
Why source drug substances from China? Large markets, economies of scale and cheaper labor;An industrial ecosystem supplying raw materials and equipment;Developed infrastructure and industry friendly...
View Article